E-mail a Wiley Online Library Link

R. J. Fontana, E. A. Hughes, M. Bifano, H. Appelman, D. Dimitrova, R. Hindes and W. T. Symonds Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C American Journal of Transplantation 13

Version of Record online: 17 APR 2013 | DOI: 10.1111/ajt.12209

A patient with severe cholestatic hepatitis C virus genotype 1b infection at nine months after liver transplantation was successfully treated with a six-month course of oral sofosbuvir in combination with daclatasvir and remains HCV RNA negative during posttreatment follow-up with improved liver biochemistries and health.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field